The consequences of discontinuing GH after linear growth is completed.
Bengtsson
Bengt-Ake
BA
Sahlgrenska University Hospital, Göteborg, Sweden.
Johannsson
Gudmundur
G
D000293:Adolescent; D000328:Adult; D001823:Body Composition / Q000502:physiology*; D001827:Body Height / Q000502:physiology; D002784:Cholesterol / Q000097:blood; D006128:Growth / Q000502:physiology*; D019382:Human Growth Hormone / Q000172:deficiency / Q000627:therapeutic use*; D006801:Humans; D007018:Hypopituitarism / Q000188:drug therapy*; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000097:blood; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D008137:Longitudinal Studies; D011788:Quality of Life
D018972:Insulin-Like Growth Factor Binding Protein 3; D019382:Human Growth Hormone; D007334:Insulin-Like Growth Factor I; D002784:Cholesterol